Clinical and dermoscopic criteria related to melanoma sentinel lymph node positivity

Anticancer Research

Volumn 27, Issue 4 C, 2007, Pages 2939-2944

  Pagnanelli, Gianluca ^a   Bono, Riccardo ^a   Pizzichetta, Maria A ^b   Talamini, Renato ^b   Ascierto, Paolo A ^c   Testori, Alessandro ^d   Stanganelli, Ignazio ^e  

^a LABORATORIO DI PATOLOGIA VASCOLARE   (Italy)

^b CENTRO DI RIFERIMENTO ONCOLOGICO   (Italy)

^c NATIONAL CANCER INSTITUTE   (Italy)

^d EUROPEAN INSTITUTE OF ONCOLOGY   (Italy)

^e OSPEDALE NIGUARDA CA GRANDA   (Italy)

Author keywords

Dermoscopy; Lymphatic mapping; Melanoma; Sentinel lymph node; TNM staging system

Indexed keywords

ADULT; ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; EPILUMINESCENCE MICROSCOPY; FEMALE; HUMAN; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; MELANOMA; PRIORITY JOURNAL; RETROSPECTIVE STUDY; RISK; SENTINEL LYMPH NODE; SENTINEL LYMPH NODE BIOPSY; STATISTICAL SIGNIFICANCE;

ADULT; AGED; AGED, 80 AND OVER; DERMOSCOPY; FEMALE; HUMANS; LYMPH NODES; LYMPHATIC METASTASIS; MALE; MELANOMA; MIDDLE AGED; RETROSPECTIVE STUDIES; SENTINEL LYMPH NODE BIOPSY;

EID: 34547731523     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (46)

1. Balch CM, Buzaid AC, Soong SJ et al: New TNM melanoma staging system: linking biology and natural history to clinical outcomes (review). Semin Surg Oncol 21: 43-52, 2003.
2. Rousseau DL Jr and Gershenwald JE: The new staging system for cutaneous melanoma in the era of lymphatic mapping (review). Semin Oncol 31: 415-425, 2004.
3. Balch CM, Soong S, Shaw HM et al: An analysis of prognostic factors in 8500 patients with cutaneous melanoma. In: Cutaneous Melanoma. Balch CM, Houghton AN and Milton GW (eds.). Philadelphia: JB Lippincott, pp. 165-176 1992.
4. Pagnanelli G, Soyer HP, Argenziano G et al: Diagnosis of pigmented skin lesions by dermoscopy: web-based training improves diagnostic performance of non-experts. Br J Dermatol 148: 698-702, 2003.
5. Soyer HP, Kenet RO, Wolf IH et al: Clinicopathological correlation of pigmented skin lesions using dermoscopy. Eur J Dermatol 10: 22-28, 2000.
6. Argenziano G, Fabbrocini G, Carli P et al: Epiluminescence microscopy: criteria of cutaneous melanoma progression. J Am Acad Dermatol 37: 68-74, 1997.
7. Carli P, De Giorgi V, Palli D et al: Preoperative assessment of melanoma thickness by ABCD score of dermatoscopy. J Am Acad Dermatol 43: 459-466, 2000.
8. Stanganelli I, Zago S, Testori A et al: Epiluminescence microscopy features of melanoma in relation to tumor thickness. Current concepts and clinical examples. Dermatol Clin 19: 285-297, 2001.
9. Armitage P and Berry G: Statistical Methods in Medical Research. Blackwell Sc. Publication, 1987.
10. Breslow NE and Day NE: Statistical methods in cancer research. Vol. I - The analysis of case-control studies. Lyon: IARC Scientific Publications No. 32, 1980.
11. Scheri RP and Essner R: Lymphatic mapping and sentinel lymphadenectomy in primary cutaneous melanoma (review). Expert Rev Anticancer Ther 6: 1105-1110, 2006.
12. Ranieri JM, Wagner JD, Wenck S, Johnson CS and Coleman JJ 3rd: The prognostic importance of sentinel lymph node biopsy in thin melanoma. Ann Surg Oncol 13: 927-932, 2006.
13. Shapiro RL: Surgical approaches to malignant melanoma. Practical guidelines (review). Dermatol Clin 20: 681-699, 2002.
14. Balch CM, Houghton AN, Sober AJ and Soong SJ (eds.). Cutaneous Melanoma. St. Louis: Quality Medical Publishing, pp. 551-571, 1998.
15. Testori A, Lazzaro G, Baldini F et al: The role of ultrasound of sentinel nodes in the pre- and post-operative evaluation of stage I melanoma patients. Melanoma Res 15: 191-198, 2005.
16. Jemal A, Thomas A, Murray T and Thin M: Cancer statistics, 2002. CA Cancer J Clin 52: 23-47, 2002.
17. Balch CM, Soong SJ, Gershenwald JE et al: Prognostic factors analysis of 17,600 melanoma patients: validation of the American Joint Committee on Cancer melanoma staging system. J Clin Oncol 19: 3622-3634, 2001.
18. Schuchter L, Schultz DJ, Synnestvedt M et al: A prognostic model for predicting 10-year survival in patients with primary melanoma. The Pigmented Lesion Group. Ann Intern Med 125: 369-375, 1996.
19. Soong SJ, Shaw HM, Balch CM et al: Predicting survival and recurrence in localized melanoma: a multivariate approach. World J Surg 16: 191-195, 1992.
20. Breslow A: Thickness, cross-sectional areas and depth of invasion in the prognosis of cutaneous melanoma. Ann Surg 172: 902-908, 1970.
21. Balch CM, Soong SJ, Atkins MB et al: An evidence-based staging system for cutaneous melanoma. CA Cancer J Clin 54: 131-149, 2004.
22. Mraz-Gernhard S, Sagebiel RW, Kashani-Sabet M et al: Prediction of sentinel lymph node micrometastasis by histological features in primary cutaneous malignant melanoma. Arch Dermatol 134: 983-987, 1998.
23. Sondak VK, Taylor JM, Sabel MS et al: Mitotic rate and younger age are predictors of sentinel lymph node positivity: lessons learned from the generation of a probabilistic model. Ann Surg Oncol 11: 247-258, 2004.
24. Gimotty PA, Elder DE, Fraker DL et al: Identification of high-risk patients among those diagnosed with thin cutaneous melanomas. J Clin Oncol 25: 1129-1134, 2007.
25. Nagore E, Oliver V, Botella-Estrada R et al: Prognostic factors in localized invasive cutaneous melanoma: high value of mitotic rate, vascular invasion and microscopic satellitosis. Melanoma Res 15: 169-177, 2005.
26. Day CL Jr, Harrist TJ, Gorstein F et al: Malignant melanoma. Prognostic significance of "microscopic satellites" in the reticular dermis and subcutaneous fat. Ann Surg 194: 108-112, 1981.
27. Straume O and Akslen LA: Independent prognostic importance of vascular invasion in nodular melanomas. Cancer 78: 1211-1219, 1996.
28. Caraco C, Marone U, Botti G, Celentano E, Lastoria S and Mozzillo N: Age as predictor in patients with cutaneous melanoma submitted to sentinel lymph node biopsy. Eur J Surg Oncol 32: 970-973, 2006.
29. Masback A, Olsson H, Westerdahl J et al: Prognostic factors in invasive cutaneous malignant melanoma: a population-based study and review. Melanoma Res 11: 435-445, 2001.
30. Slingluff CL Jr, Vollmer RT, Reintgen DS and Seigler HF: Lethal "thin" malignant melanoma. Identifying patients at risk. Ann Surg 208: 150-161, 1988.
31. Vossaert KA, Silverman MK, Kopf AW et al: Influence of gender on survival in patients with stage I malignant melanoma (review). J Am Acad Dermatol 26: 429-440, 1992.
32. Gimotty PA, Guerry D, Ming ME et al: Thin primary cutaneous malignant melanoma: a prognostic tree for 10-year metastasis is more accurate than American Joint Committee on Cancer staging. J Clin Oncol 22: 3668-3676, 2004.
33. Kopf AW, Welkovich B, Frankel RE et al: Thickness of malignant melanoma: global analysis of related factors. J Dermatol Surg Oncol 13: 345-390 and 401-420, 1987.
34. Taylor BA and Hughes LE: A policy of selective excision for primary cutaneous malignant melanoma. Eur J Surg Oncol 11: 7-13, 1985.
35. Funk W, Schmoeckel C, Holzel D and Braun-Falco O: Prognostic classification of malignant melanoma by clinical criteria. Br J Dermatol 111: 129-138, 1984.
36. O'Donnell BF, Marsden JR, O'Donnell CA et al: Does palpability of primary cutaneous melanoma predict dermal invasion? J Am Acad Dermatol 34: 632-637, 1996.
37. Argenziano G, Fabbrocini G, Carli P et al: Clinical and dermatoscopic criteria for the preoperative evaluation of cutaneous melanoma thickness. J Am Acad Dermatol 40: 61-68, 1999.
38. Fontaine D, Parkhill W, Greer W and Walsh N: Partial regression of primary cutaneous melanoma: is there an association with sub-clinical sentinel lymph node metastasis? Am J Dermatopathol 25: 371-376, 2003.
39. McGovern VJ, Shaw HM and Milton GW: Prognosis in patients with thin malignant melanoma: influence of regression. Histopathology 7: 673-680, 1983.
40. Paladugu RR and Yonemoto RH: Biologic behaviour of thin malignant melanomas with regressive changes. Arch Surg 118: 41-44, 1983.
41. Trau H, Rigel DS, Harris MN et al: Metastases of thin melanomas. Cancer 51: 553-556, 1983.
42. Weissmann A, Roses DF, Harris MN and Dubin N: Prediction of lymph node metastases from the histologic features of primary cutaneous malignant melanomas. Am J Dermatopathol 6 Suppl: 35-41, 1984.
43. Naruns PL, Nizze JA, Cochran AJ, Lee MB and Morton DL: Recurrence potential of thin primary melanomas. Cancer 57: 545-548,1986.
44. Sondegard K and Hou-Jensen K: Partial regression in thin primary cutaneous malignant melanomas clinical stage I. A study of 486 cases. Virchows Arch A Pathol Anat Histopathol 408: 241-247, 1985.
45. Liszkay G, Orosz Z, Peley G et al: Relationship between sentinel lymph node status and regression of primary malignant melanoma. Melanoma Res 15: 509-513, 2005.
46. Stolz W, Semmelmayer U, Johow K and Burgdorf WH: Principles of dermatoscopy of pigmented skin lesions. Semin Cutan Med Surg (review) 22: 9-20, 2003.